GlassScriptPhysician profile
Steven M Fendley
NPI 1396740577
$32,922.57
in general payments reported to CMS, 2019-2025
35 companies · $5,446 in 2025
The $5,446 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,958 · 2020: $4,392 · 2021: $1,632 · 2022: $3,720 · 2023: $1,523 · 2024: $11K · 2025: $5,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Travel and Lodging: $2,290 · Food and Beverage: $1,681 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,000.00 |
| Travel and Lodging | $2,289.82 |
| Food and Beverage | $1,681.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $30,532.44 | 2019-2025 | Da Vinci Surgical System |
| Organogenesis INC. | $443.26 | 2019-2024 | Puraply |
| Baxter Healthcare | $227.18 | 2020-2022 | |
| Conmed Corporation | $226.04 | 2022-2024 | Airseal |
| Myriad Genetic Laboratories, INC. | $205.24 | 2021-2024 | Bracanalysis, Bracanalysis Cdx |
| Tela Bio, INC. | $203.04 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $145.22 | 2019-2020 | |
| Integra Lifesciences Corporation | $141.13 | 2020-2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Genentech USA, INC. | $134.62 | 2019 | |
| Davol INC. | $76.19 | 2022-2024 | Phasix Mesh |
| Depuy Synthes Sales INC. | $59.84 | 2020-2021 | |
| Angiodynamics, INC. | $56.38 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Hologic INC | $45.53 | 2022 | |
| Kerecis Limited | $42.13 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Janssen Pharmaceuticals, INC | $34.44 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $26.63 | 2022-2023 | Seglentis |
| Ossur Americas, INC. | $25.70 | 2025 | |
| Hologic Sales and Service, LLC | $24.45 | 2025 | Trunode, Trident Specimen Radiography System, Localizer |
| Merck Sharp & Dohme LLC | $22.02 | 2023 | |
| Kci USA, INC. | $21.03 | 2023 | Prevena, V.A.C. Veraflo |
| Takeda Pharmaceuticals U.S.A., INC. | $21.02 | 2023 | Gattex |
| Bard Peripheral Vascular, INC. | $19.92 | 2024 | |
| Smith+Nephew, INC. | $17.70 | 2023 | Collagenase Santyl |
| Z-Medica, LLC | $17.35 | 2019 | |
| Aroa Biosurgery Incorporated | $16.46 | 2023 | |
| Braintree Laboratories, INC. | $16.27 | 2023 | Suflave |
| Lilly USA, LLC | $15.27 | 2024 | Zepbound |
| Solventum Corporation | $14.69 | 2024 | V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Standard Bariatrics, INC. | $14.35 | 2022 | |
| Cook Medical LLC | $14.10 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.68 | 2019 | |
| Ethicon US, LLC | $13.29 | 2021 | |
| Tei Biosciences INC | $12.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.57 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $10.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Fendley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.